Amgen News

Amgen Analyst Ratings

BenzingaJun 14 09:32 ET

Research Alert: CFRA Adds Amgen Inc. To The High-quality Capital Appreciation Portfolio

MT NewswiresJun 12 00:20 ET

Barclays Sticks to Its Hold Rating for Amgen (AMGN)

TipRanksMay 21 03:46 ET

HSBC Adjusts Price Target on Amgen to $356 From $322

MT NewswiresMay 20 07:48 ET

Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating

MT NewswiresMay 13 05:53 ET

Amgen Analyst Ratings

BenzingaMay 9 07:48 ET

Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170

MT NewswiresMay 9 06:44 ET

Mizuho Securities Raises Amgen's Price Target to $235 From $223

MT NewswiresMay 8 14:13 ET

Amgen Analyst Ratings

BenzingaMay 3 10:08 ET

RBC Capital Reaffirms Their Buy Rating on Amgen (AMGN)

TipRanksMay 3 06:43 ET

Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating

MT NewswiresMay 3 05:43 ET

Amgen Analyst Ratings

BenzingaApr 17 05:57 ET

Amgen Analyst Ratings

BenzingaApr 12 11:59 ET

Amgen Analyst Ratings

BenzingaApr 3 08:45 ET

Amgen Analyst Ratings

BenzingaMar 28 13:06 ET

Barclays Sticks to Their Sell Rating for Amgen (AMGN)

TipRanksFeb 23 03:15 ET

Amgen Analyst Ratings

BenzingaFeb 8 10:32 ET

Amgen Stock Downgraded Amid Obesity Drug Uncertainty

InvestingFeb 7 10:58 ET

Oppenheimer Adjusts Amgen Price Target to $380 From $350, Maintains Outperform Rating

MT NewswiresFeb 7 09:22 ET

Amgen Analyst Ratings

BenzingaFeb 7 08:27 ET